Viral myocarditis: from experimental models to molecular diagnosis in patients

@article{Pankuweit2012ViralMF,
  title={Viral myocarditis: from experimental models to molecular diagnosis in patients},
  author={Sabine Pankuweit and Karin Klingel},
  journal={Heart Failure Reviews},
  year={2012},
  volume={18},
  pages={683-702}
}
Cardiotropic viruses have been implicated as major pathogenetic agents in acute and chronic forms of myocarditis. By the introduction of molecular tools, such as (RT-) polymerase chain reaction ((RT-) PCR) and in situ hybridization in the diagnosis of inflammatory heart disease, genomes of various RNA and DNA viruses comprising enteroviruses, adenoviruses, parvovirus B19 (B19V) and herpesviruses (EBV, HHV6, HCMV) were detected in endomyocardial biopsies of patients with myocarditis and dilated… Expand
Viral Myocarditis: From Experimental Models to Diagnosis in Patients
TLDR
By investigation of immunocompetent and gene-targeted mice valuable new insights into host and virus factors relevant for the control of cardiac viral infection and inflammation were gained which are reviewed in this paper. Expand
Molecular Pathobiology of Myocarditis
TLDR
This chapter will focus on the diagnostic role of molecular tools as well as on the pathogenetic pathways involved in disease onset and progression, including host, viral genetics, and environmental factors. Expand
Myocarditis in Humans and in Experimental Animal Models
TLDR
This review describes the most commonly used mouse models of experimental myocarditis with a focus on the role of the innate and adaptive immune systems in induction and progression of the disease. Expand
Autoimmunity in viral myocarditis
TLDR
Antigenic mimicry between microbes and cardiac proteins causes autoimmunity in myocarditis, and characteristics of innate immunity associated with cardiac infection determine relevant epitope expression (cryptic epitopes). Expand
Viral presence guided immunomodulation in lymphocytic myocarditis: An update
TLDR
This review systematically discusses the unsolved issues of immunomodulation guided by viral presence in acute lymphocytic myocarditis, namely virus epidemiology and prognosis, variability of viral presence rates, the role of potential viral bystander findings, and the main results of immunosuppression controlled trials in lymphocytes. Expand
Viral Myocarditis and Dilated Cardiomyopathy: Mechanisms of Cardiac Injury, Inflammation, and Fibrosis
TLDR
Chronic inflammation is likely due to autoimmunity, persistent viral infection in the heart, and an attempt to heal scar tissue laid down as a consequence of acute inflammation-induced remodeling. Expand
The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts
TLDR
The detection of PVB in myocardial autopsy samples most likely represents a persistent infection with no or limited association with myocardia inflammation, and was found to be rare causes of myocarditis. Expand
The spectrum of myocarditis: from pathology to the clinics
TLDR
The elements supporting an aetiology-driven diagnostic work-up in myocarditis are reviewed, emphasizing the importance of integrating pathologic studies with clinical features and information derived from multimodality imaging and the potential of transcriptomic and proteomic analysis. Expand
First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child.
TLDR
Artesunate can be considered as an effective candidate for clinical use in cases of HHV-6B associated myocarditis and is supported by histological and viral diagnoses via a combination of histology/immunohistochemistry and polymerase chain reaction techniques. Expand
Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options
TLDR
Clinical management of the disease entity at the acute stage involves hemodynamic monitoring in an intensive care unit or similar setting and immunosuppressive treatment is beneficial; for viral myocarditis, IVIg can resolve the inflammation, reduce the viral load, and even eradicate the microbial agent. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 202 REFERENCES
Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.
TLDR
The underlying dominant pathophysiological mechanisms in a large cohort of 3345 consecutive patients with left ventricular dysfunction evaluated over a period of 10 years were revealed, including parvovirus B19 genome, which was significantly correlated with inflammatory heart disease and reduced ejection fraction. Expand
Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction.
TLDR
Parvovirus genome identified through PCR analysis of cardiac tissue in the clinical setting of myocarditis and cardiac allograft rejection may be a potential contributor to cardiac transplant rejection. Expand
Virus serology in patients with suspected myocarditis: utility or futility?
TLDR
For patients with suspected myocarditis, virus serology has no relevance for the diagnosis of myocardial infection and endomyocardial biopsy remains the gold standard in the diagnostic of viralMyocarditis. Expand
Cytomegalovirus infection of the heart is common in patients with fatal myocarditis.
TLDR
In this population-based study, cytomegalovirus was found to be the most common specific finding in immunocompetent patients with fatal myocarditis and may have important clinical implications for the treatment of severe acuteMyocarditis. Expand
Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction
TLDR
In this first biopsy-based analysis of the course of viral heart disease, it is shown that EV, ADV, PVB19, and HHV6 persistence detected in the myocardium of patients with LV dysfunction was associated with a progressive impairment of LVEF, whereas spontaneous viral elimination wasassociated with a significant improvement in LV function. Expand
Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation.
TLDR
There are therapeutic implications from the in situ demonstration of myocardial enterovirus infection, and Evaluation of specific antiviral agents, for example interferons, may lead to the development of new therapeutic strategies capable of providing protection against myocardials infection. Expand
Viral Myocarditis: From the Perspective of the Virus
TLDR
A clinical paradigm that focuses on the phases of viral infection and the molecular insights that are important for these phases of the infectious process with a focus on interactions between the virus and the cardiac myocyte is proposed. Expand
Acute Myocarditis Rapid Diagnosis by PCR in Children
TLDR
PCR offers a rapid, sensitive diagnostic method for myocardial viral infection while enterovirus is an important etiological agent, adenovirus was more prevalent in this series and should be evaluated when etiology is sought. Expand
Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence.
TLDR
The findings suggest that maintenance of the chronic phase of myocarditis involving post-viral immunological responses can occur in the presence of little infectious virus replication in the heart, suggesting latent viral infection of the heart. Expand
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
TLDR
The rather discouraging results obtained to date with immunosuppressive agents in the treatment of viral myocarditis indicated the importance of sparing neutralizing antibody production, which may be controlled by B cells, and raised the possibility of promising developments in immunomodulating therapy. Expand
...
1
2
3
4
5
...